Convalescent plasma therapy for COVID-19: state of the art

D Focosi, AO Anderson, JW Tang… - Clinical microbiology …, 2020 - Am Soc Microbiol
Convalescent plasma (CP) therapy has been used since the early 1900s to treat emerging
infectious diseases; its efficacy was later associated with the evidence that polyclonal …

Reinfection with SARS-CoV-2: implications for vaccines

JI Cohen, PD Burbelo - Clinical Infectious Diseases, 2021 - academic.oup.com
Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become
pandemic and the duration of protective immunity to the virus is unknown. Cases of persons …

[HTML][HTML] Use of convalescent plasma therapy in two COVID-19 patients with acute respiratory distress syndrome in Korea

JY Ahn, Y Sohn, SH Lee, Y Cho, JH Hyun… - Journal of Korean …, 2020 - ncbi.nlm.nih.gov
Abstract Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus-2 not yet has established its treatment, but convalescent plasma has …

Emergence of a novel human coronavirus threatening human health

LLM Poon, M Peiris - Nature medicine, 2020 - nature.com
Emergence of a novel human coronavirus threatening human health | Nature Medicine Skip to
main content Thank you for visiting nature.com. You are using a browser version with limited …

[HTML][HTML] Sustained cellular immune dysregulation in individuals recovering from SARS-CoV-2 infection

JK Files, S Boppana, MD Perez… - The Journal of …, 2021 - Am Soc Clin Investig
Ongoing observational clinical research has prioritized understanding the human immune
response to SARS-CoV-2 during the coronavirus disease 2019 (COVID-19) pandemic …

Epidemiological research priorities for public health control of the ongoing global novel coronavirus (2019-nCoV) outbreak

BJ Cowling, GM Leung - Eurosurveillance, 2020 - eurosurveillance.org
It is now 6 weeks since Chinese health authorities announced the discovery of a novel
coronavirus (2019-nCoV)[1] causing a cluster of pneumonia cases in Wuhan, the major …

[PDF][PDF] Clinical management of severe acute respiratory infection when Middle East respiratory syndrome coronavirus (MERS-CoV) infection is suspected: interim …

World Health Organization - 2019 - apps.who.int
The first edition of this document was published in 2013 and was revised in 2015. The
current version is aligned with other WHO documents on case definitions and laboratory …

Immunoglobulins in the treatment of COVID-19 infection: Proceed with caution!

AA Nguyen, SB Habiballah, CD Platt, RS Geha… - Clinical …, 2020 - Elsevier
The COVID-19 pandemic is one of the greatest infectious challenges in recent history.
Presently, few treatment options exist and the availability of effective vaccines is at least one …

An mRNA vaccine against SARS-CoV-2—preliminary report

LA Jackson, EJ Anderson, NG Rouphael… - New England journal …, 2020 - Mass Medical Soc
Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged
in late 2019 and spread globally, prompting an international effort to accelerate …

Quality of life reported by survivors after hospitalization for Middle East respiratory syndrome (MERS)

S Batawi, N Tarazan, R Al-Raddadi, E Al Qasim… - Health and quality of life …, 2019 - Springer
Introduction Data are lacking on impact of Middle East Respiratory Syndrome (MERS) on
health-related quality of life (HRQoL) among survivors. Methods We conducted a cross …